Literature DB >> 23506383

Prevalence of diabetes and impaired glucose metabolism in younger 'at risk' UK adults: insights from the STAND programme of research.

E G Wilmot1, C L Edwardson, S J H Biddle, T Gorely, J Henson, K Khunti, M A Nimmo, T Yates, M J Davies.   

Abstract

AIMS: Rising rates of obesity have led to an increasing prevalence of Type 2 diabetes mellitus in young people. Uncertainty exists over the utility of screening younger adults for Type 2 diabetes, as existing data sets have focused on mature (> 40 years) cohorts. The aim of this study was to determine the prevalence of impaired glucose metabolism in higher risk younger adults.
METHODS: Overweight (with an additional risk factor) or obese adults (18-40 years) were recruited for the Sedentary Time And Diabetes (STAND) randomized controlled trial. Measures included an oral glucose tolerance test, HbA1c , biochemical and anthropometric data.
RESULTS: One hundred and ninety-three individuals (68% female; median age 33.8 years; median BMI 33.9 kg/m²) were recruited. Forty-three per cent had a first-degree family history of Type 2 diabetes. Previously undiagnosed Type 2 diabetes was present in 4.7% (n = 9). Of participants, 18.1% (n = 35) had impaired glucose metabolism: 4.7% (n = 9) HbA1c ≥ 48 mmol/mol (6.5%); 9.3% (n = 18) HbA1c 42-46 mmol/mol (6.0-6.4%); 3.1% (n = 6) Type 2 diabetes on oral glucose tolerance test; 6.2% (n = 12) isolated impaired glucose tolerance; 2.1% (n = 4) isolated impaired fasting glucose; 1% (n = 2) both impaired fasting glucose and impaired glucose tolerance. Of participants, 58.5% (n = 113) had dyslipidaemia, 28.0% (n = 54) had hypertension, 31.1% (n = 60) were vitamin D deficient and 7.3% (n = 14) had abnormal liver function.
CONCLUSIONS: This study identified a high prevalence of Type 2 diabetes and impaired glucose regulation in overweight and obese younger adults. These findings require confirmation in a larger, representative, population.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Year:  2013        PMID: 23506383     DOI: 10.1111/dme.12173

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  15 in total

1.  Evaluation of 25(OH) Vitamin D3 with Reference to Magnesium Status and Insulin Resistance in T2DM.

Authors:  Mahendra Bhauraoji Gandhe; Keerthi Jain; Swapnali Mahendra Gandhe
Journal:  J Clin Diagn Res       Date:  2013-10-23

2.  Prevalence of Metabolic Syndrome and Impaired Glucose Metabolism among 10- to 17-Year-Old Overweight and Obese Lithuanian Children and Adolescents.

Authors:  Natalija Smetanina; Raimondas Valickas; Astra Vitkauskiene; Kerstin Albertsson-Wikland; Rasa Verkauskienė
Journal:  Obes Facts       Date:  2021-05-05       Impact factor: 3.942

3.  Periodontitis is not associated with metabolic risk during the fourth decade of life.

Authors:  Dara M Shearer; W Murray Thomson; Jonathan M Broadbent; Jim Mann; Richie Poulton
Journal:  J Clin Periodontol       Date:  2016-12-05       Impact factor: 8.728

Review 4.  Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Authors:  Joanna M Bilak; Uazman Alam; Christopher A Miller; Gerry P McCann; Jayanth R Arnold; Prathap Kanagala
Journal:  Card Fail Rev       Date:  2022-07-01

5.  Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population.

Authors:  Soon H Song
Journal:  BMJ Open Diabetes Res Care       Date:  2015-02-17

Review 6.  Does sufficient evidence exist to support a causal association between vitamin D status and cardiovascular disease risk? An assessment using Hill's criteria for causality.

Authors:  Patricia G Weyland; William B Grant; Jill Howie-Esquivel
Journal:  Nutrients       Date:  2014-09-02       Impact factor: 5.717

7.  High-risk glycated hemoglobin trajectories established by mid-20s: findings from a birth cohort study.

Authors:  Dara M Shearer; W Murray Thomson; Jonathan M Broadbent; Rachael McLean; Richie Poulton; Jim Mann
Journal:  BMJ Open Diabetes Res Care       Date:  2016-08-24

8.  Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I): a randomised controlled trial to examine the impact of an intensive lifestyle intervention consisting of a low-energy diet and physical activity on body weight and metabolism in early type 2 diabetes mellitus: study protocol for a randomized controlled trial.

Authors:  Shahrad Taheri; Odette Chagoury; Hadeel Zaghloul; Sara Elhadad; Salma Hayder Ahmed; Omar Omar; Sherryl Payra; Salma Ahmed; Neda El Khatib; Rasha Abou Amona; Katie El Nahas; Matthew Bolton; Henem Chaar; Noor Suleiman; Amin Jayyousi; Mahmoud Zirie; Ibrahim Janahi; Wahiba Elhag; Abdulla Alnaama; Abduljaleel Zainel; Dahlia Hassan; Tim Cable; Mary Charlson; Martin Wells; Abdulla Al-Hamaq; Samya Al-Abdulla; Abdul Badi Abou-Samra
Journal:  Trials       Date:  2018-05-21       Impact factor: 2.279

Review 9.  Diabetic cardiomyopathy: prevalence, determinants and potential treatments.

Authors:  Gaurav S Gulsin; Lavanya Athithan; Gerry P McCann
Journal:  Ther Adv Endocrinol Metab       Date:  2019-03-27       Impact factor: 3.565

10.  A Randomised Controlled Trial to Reduce Sedentary Time in Young Adults at Risk of Type 2 Diabetes Mellitus: Project STAND (Sedentary Time ANd Diabetes).

Authors:  Stuart J H Biddle; Charlotte L Edwardson; Emma G Wilmot; Thomas Yates; Trish Gorely; Danielle H Bodicoat; Nuzhat Ashra; Kamlesh Khunti; Myra A Nimmo; Melanie J Davies
Journal:  PLoS One       Date:  2015-12-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.